Find the Perfect Plan for Your Investment Journey
Q
Latest price
52 Week Range
- - -
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | CA$25.71M |
EV | CA$15.04M |
Shares Outstanding | 2.75M |
Beta | 0.69 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2021E | - |
P/Revenue 2021E | - |
Revenue | - |
EPS | -469.60% |
Operating Cash Flow | -403.50% |
Free Cash Flow | -28.20% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2021E | - |
Net Profit Margin 2021E | - |
ROE 2021E | - |
ROCE 2020 | -78.40% |
DPS 2021E | - |
Payout Ratio 2021E | - |
Div. Yield 2021E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Q
Quantum BioPharma Ltd.
QNTM
Sector
Industry
CEO
Saeed, Zeeshan
Employees
17
Website
www.fsdpharma.comIPO Date
Headquarters
55 University Ave., Suite 1003, Toronto, Ontario, M5J 2H7, Canada
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved